Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Evofem Biosciences stock | $2.16

Own Evofem Biosciences stock in just a few minutes.

Fact checked

Evofem Biosciences, Inc is a biotechnology business based in the US. Evofem Biosciences shares (EVFM) are listed on the NASDAQ and all prices are listed in US Dollars. Evofem Biosciences employs 53 staff and has a trailing 12-month revenue of around USD$278,000.

How to buy shares in Evofem Biosciences

  1. Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table.
  2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
  3. Search for Evofem Biosciences. Find the stock by name or ticker symbol: EVFM. Research its history to confirm it's a solid investment against your financial goals.
  4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Evofem Biosciences reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
  5. Decide on how many to buy. At last close price of USD$2.16, weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of Evofem Biosciences, depending on your broker.
  6. Check in on your investment. Congratulations, you own a part of Evofem Biosciences. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

Evofem Biosciences share price

Use our graph to track the performance of EVFM stocks over time.

Evofem Biosciences shares at a glance

Information last updated 2020-12-27.
Latest market closeUSD$2.16
52-week rangeUSD$1.91 - USD$7.21
50-day moving average USD$2.2363
200-day moving average USD$2.6916
Wall St. target priceUSD$8.4
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) USD$-3.008

Buy Evofem Biosciences shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Stock trade fee Asset types Option trade fee Annual fee
Sofi Invest
Stocks, ETFs, Cryptocurrency
A free way to invest in stocks, ETFs and crypto.
Stocks, Options, ETFs, Cryptocurrency
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
$0 for US stocks
Stocks, Options, ETFs
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.
TD Ameritrade
or $25 broker-assisted
$0 + $0.65/contract,
or $25 broker-assisted
TD Ameritrade features $0 commission for online stock, but watch out for high short-term ETF and broker-assisted trading fees.

Compare up to 4 providers

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Evofem Biosciences stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Evofem Biosciences price performance over time

Historical closes compared with the close of $2.16 from 2020-12-09

1 week (2021-01-08) -15.29%
1 month (2020-12-16) 4.35%
3 months (2020-10-15) -24.74%
6 months (2020-07-15) -26.78%
1 year (2020-01-15) -64.88%
2 years (2019-01-15) -45.32%
3 years (2018-01-12) 14.29%
5 years (2016-01-15) 107.69%

Evofem Biosciences financials

Revenue TTM USD$278,000
Gross profit TTM USD$0
Return on assets TTM -66.54%
Return on equity TTM -356%
Profit margin 0%
Book value $0.495
Market capitalisation USD$191.8 million

TTM: trailing 12 months

Shorting Evofem Biosciences shares

There are currently 7.3 million Evofem Biosciences shares held short by investors – that's known as Evofem Biosciences's "short interest". This figure is 7.2% down from 7.8 million last month.

There are a few different ways that this level of interest in shorting Evofem Biosciences shares can be evaluated.

Evofem Biosciences's "short interest ratio" (SIR)

Evofem Biosciences's "short interest ratio" (SIR) is the quantity of Evofem Biosciences shares currently shorted divided by the average quantity of Evofem Biosciences shares traded daily (recently around 1.8 million). Evofem Biosciences's SIR currently stands at 4.02. In other words for every 100,000 Evofem Biosciences shares traded daily on the market, roughly 4020 shares are currently held short.

However Evofem Biosciences's short interest can also be evaluated against the total number of Evofem Biosciences shares, or, against the total number of tradable Evofem Biosciences shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Evofem Biosciences's short interest could be expressed as 0.12% of the outstanding shares (for every 100,000 Evofem Biosciences shares in existence, roughly 120 shares are currently held short) or 0.2115% of the tradable shares (for every 100,000 tradable Evofem Biosciences shares, roughly 212 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Evofem Biosciences.

Find out more about how you can short Evofem Biosciences stock.

Evofem Biosciences share dividends

We're not expecting Evofem Biosciences to pay a dividend over the next 12 months.

Have Evofem Biosciences's shares ever split?

Evofem Biosciences's shares were split on a 1:6 basis on 18 January 2018. So if you had owned 6 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Evofem Biosciences shares – just the quantity. However, indirectly, the new 500% higher share price could have impacted the market appetite for Evofem Biosciences shares which in turn could have impacted Evofem Biosciences's share price.

Evofem Biosciences share price volatility

Over the last 12 months, Evofem Biosciences's shares have ranged in value from as little as $1.91 up to $7.21. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Evofem Biosciences's is -0.3889. This would suggest that Evofem Biosciences's shares have been inversely-correlated to the average (for this exchange) – so when the broader market trended up or down, Evofem Biosciences has bucked the trend.

Evofem Biosciences overview

Evofem Biosciences, Inc., a biopharmaceutical company, develops and commercializes various products to address unmet needs in women's sexual and reproductive health. Its commercial product is Phexxi, a vaginal gel for the prevention of pregnancy. The company is also involved in the development of EVO100, a vaginal pH regulator for the prevention of urogenital transmission of Chlamydia trachomatis infection and Neisseria gonorrhoeae infection in women. Evofem Biosciences, Inc. is headquartered in San Diego, California.

Frequently asked questions

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site